Growth Metrics

Utah Medical Products (UTMD) Current Leases (2022 - 2023)

Utah Medical Products' quarterly Current Leases came in at $47000.0 in Q4 2023, down 12.96% year-on-year from $54000.0 in Q4 2022, and down 12.96% quarter-over-quarter from $54000.0 in Q4 2022.

Utah Medical Products has reported Current Leases for 2 years, with the latest figure at $47000.0 in Q4 2023.

  • For the quarter ending Q4 2023, Current Leases fell 12.96% year-over-year to $47000.0; the trailing twelve-month figure through Dec 2023 stood at $47000.0 (down 12.96% YoY), and the FY2023 full-year result was $47000.0, down 12.96% from the prior year.
  • Current Leases for Q4 2023 stood at $47000.0, down from $54000.0 in the prior quarter.
  • The five-year high for Current Leases was $54000.0 in Q4 2022, with the low at $47000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 29.23 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 21.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Utah Medical Products 204.80 Mn 117.39 Mn 5.28 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 47,000.00
Dec 31, 2022 54,000.00